Implant-to-Market · Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Project objective

Implant-to-Market will be a Doctoral Network (combining training and research) composed of 15 academic partners and 5 industrial partners (large companies and SMEs), focused on accelerating the translation of research into market-ready surgical implantable medical devices. Despite major scientific advances, the medical device sector, particularly implantable devices for surgery, still faces slow innovation transfer due to fragmented regulatory knowledge, limited cross-talk between scientists and regulatory experts, and shortages of skilled personnel. Training is therefore essential to reinforce innovation capacity and global competitiveness. A European doctoral network integrating training and research is the most relevant instrument to address these challenges. The training programme developed in this project will be sustained beyond the project, and the qualifications of doctoral candidates and early-career researchers will be established by the consortium using shared methodologies.The research methodology will rely on multidisciplinary and cross-sectoral collaborations involving universities, hospitals and industry. The work packages will address key needs: (i) integrating scientific data into regulatory processes and improving regulatory understanding among researchers; (ii) assessing safety and performance of implantable medical devices; (iii) reducing animal testing through alternative methods; (iv) developing multi-personalized and advanced medical devices; and (v) implementing sustainable-by-design strategies. Expected outcomes include improved regulatory-science practices, enhanced qualification pathways, accelerated translation of innovations, and stronger interaction between research, clinics, regulation and industry. implant-to-market will help bridge the gap between scientific discovery and clinical adoption worldwide.

Original text from CORDIS.

Participants

• INSTITUT NATIONAL POLYTECHNIQUE DE TOULOUSE · Toulouse Cedex 4CoordinatorFrance
• 3DEUS DYNAMICS SAS · VilleurbanneFrance
• ACM PHARMA · BellegardeCity levelFrance
• CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE · TOULOUSE CEDEX 3France
• CERHUM · LIEGEBelgium
• DR. H. C. ROBERT MATHYS STIFTUNG FUR FORSCHUNG, DIENSTLEISTUNG, TECHNOLOGIETRANSFER UND DIE AUSBILDUNGSFORDERUNG IN DER MEDIZINAL - UND WERKSTOFFTECHNIK · BETTLACHSwitzerland
• EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH · ZuerichSwitzerland
• EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT · DubendorfSwitzerland
• FONDATION HOPITAL SAINT JOSEPH · PARISFrance
• FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV · MunchenGermany
• Lipal Biochemicals SA · GundetswilSwitzerland
• POLITECNICO DI TORINO · TorinoItaly
• SOFRADIM PRODUCTION SASU · TrevouxFrance
• STICHTING RADBOUD UNIVERSITEIT · NijmegenNetherlands
• UNIVERSIDAD POLITECNICA DE MADRID · MadridSpain
• UNIVERSIDADE DO PORTO · PortoPortugal
• UNIVERSITA DEGLI STUDI DI PADOVA · PadovaItaly
• UNIVERSITAET BERN · BernSwitzerland
• UNIVERSITE DE LIEGE · LIEGEBelgium
• UNIVERSITE DE TOULOUSE · ToulouseFrance

Links

• View on CORDIS
• DOI: 10.3030/101311759